Artificial intelligence news and machine learning news

News and Trends 28 Sep 2022

AION Labs launches AI startup to improve drug trials

AION Labs has formed OMEC.AI, the lab’s first startup approved by the Israel Innovation Authority. The new company will develop AI-powered solutions to analyze pre-clinical data and identify gaps in efficacy and safety to improve the probability of success of drug candidates in clinical trials. OMEC.AI aims to build a next-generation computational platform that can […]

September 28, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 28 Sep 2022

Spoonshot on how foodtech can reduce food waste

With the International Day of Awareness of Food Loss and Waste just around the corner, Labiotech caught up with Spoonshot co-founder and CEO Kishan Vasani to find out how the foodtech sector can tackle food waste. Spoonshot is a software platform for food and beverage professionals that delivers category intelligence by leveraging data from more […]

September 28, 2022 - 3 minutesmins - By Jim Cornall

Cleara Biotech closes $2.5M round for senescence treatment

News and Trends 26 Sep 2022

Surge raises $2.6M in funding for technology and secures exclusive licensing agreement

Surge, a biotech and artificial intelligence innovator that produces technology to decode immune fingerprints, has received $2.6 million in funding. The technology accurately identifies patients at risk before surgery and enables physicians to quickly forecast the risk of postoperative complications. The funding round was co-led by HCVC, a global early-stage fund dedicated to high-potential […]

September 26, 2022 - 4 minutesmins - By Liza Laws

Optics11 Life receives €5 million in funding for drug development

News and Trends 21 Sep 2022

Quinten Health closes financing round to advance disease modeling platforms

A financing round to advance disease modeling platforms and virtual twins in real world has been closed by Quinten Health. The company that works in real-world data science, artificial intelligence (AI) and machine learning (ML) for precision care, made the announcement today (September 21). The round is part of the Quinten Group’s €14 million ($13.9 […]

September 21, 2022 - 3 minutesmins - By Liza Laws

News and Trends 20 Sep 2022

CytoReason and Pfizer agree deal worth up to $110M for AI drug discovery and development

In a deal with a potential value of $110 million over the next five years, CytoReason has announced an extension of its multi-year partnership with Pfizer. Pfizer will make a $20 million equity investment under the terms of the agreement which will give the company the right to use CytoReason’s artificial intelligence (AI) technology and […]

September 20, 2022 - 3 minutesmins - By Liza Laws

Startup Scout 15 Sep 2022

Adva Biotechnology is using artificial intelligence to manufacture cell therapies

The manufacturing of cell therapies is highly complex, often depending on skilled manual labor. The Israeli startup Adva Biotechnology aims to use automation, optical sensing and artificial intelligence to remove the manual component from the process. Cancer cell therapies such as CAR-T immunotherapies have demonstrated enormous potential for treating forms of blood cancer. Currently available […]

September 15, 2022 - 4 minutesmins - By Jonathan Smith

News and Trends 14 Sep 2022

Recursion adds FAP and C. diff clinical trials

Recursion Pharmaceuticals has initiated two additional clinical trials including its first in-house generated new chemical entity to enter the clinic. The phase 2 TUPELO clinical trial is evaluating REC-4881 for the potential treatment of familial adenomatous polyposis (FAP) in patients who have previously undergone a colectomy/proctocolectomy. REC-4881 is an orally bioavailable, non-ATP-competitive allosteric small molecule […]

September 14, 2022 - 4 minutesmins - By Jim Cornall

News and Trends 13 Sep 2022

WhiteLab Genomics raises $10M for AI-powered genomic therapies platform

WhiteLab Genomics has announced the completion of a $10 million funding round. The round was led by French venture capital firm Omnes Capital, and Debiopharm, a Switzerland based biopharmaceutical company with a venture arm focused on digital health. WhiteLab Genomics said it aims to “revolutionize genomic therapy development” using public and private data and in-house […]

September 13, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 13 Sep 2022

New predictive biomarkers to be developed for larynx and hypopharynx carcinomas

A study to develop new, potential precision therapies in larynx and hypopharynx carcinomas has been announced today (September 13) by One Biosciences. The company was co-founded by Céline Vallot, Institut Curie and Home Biosciences, combining artificial intelligence (AI) and single-cell technologies to discover new therapeutic targets and develop novel precision medicines. The LARYCARE study, for […]

September 13, 2022 - 2 minutesmins - By Liza Laws

News and Trends 13 Sep 2022

Arpeggio Biosciences raises $17M in Series A funding to support drug pipeline

Arpeggio Biosciences has raised $17 million in series A funding in a round led by Builders VC. Support for the U.S.-based preclinical therapeutics company making technology targeting transcriptional dysregulation in disease, also came from its seed round investors. These include Khosla Ventures, TechU Ventures, FundersClub, Alice Zhang, and Fifty Years, as well as new participants […]

September 13, 2022 - 2 minutesmins - By Liza Laws

News and Trends 8 Sep 2022

Report looks at the future of clinical trials

Medidata, a Dassault Systèmes company, has published a report, ‘European Industry Research Report: The Future of Clinical Trials’. The report draws on new independent research that includes insights from 400 clinical trial executives across the U.K., France, Germany and Switzerland. They were surveyed to gain a deeper understanding of how clinical trials have changed over […]

September 8, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 6 Sep 2022

Finnish researchers use machine learning to unlock clinical cancer samples’ genomic code

A new paper from the University of Helsinki, published in Nature Communications, suggests a method for accurately analyzing genomics data in archival cancer biopsies. The tool uses machine learning methods to correct damaged DNA and unveil the true mutation processes in tumor samples. This helps to unlock medicine values in millions of archival cancer samples. […]

September 6, 2022 - 2 minutesmins - By Jim Cornall

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Artificial intelligence

AION Labs launches AI startup to improve drug trials

Spoonshot on how foodtech can reduce food waste

Surge raises $2.6M in funding for technology and secures exclusive licensing agreement

Quinten Health closes financing round to advance disease modeling platforms

CytoReason and Pfizer agree deal worth up to $110M for AI drug discovery and development

Adva Biotechnology is using artificial intelligence to manufacture cell therapies

Recursion adds FAP and C. diff clinical trials

WhiteLab Genomics raises $10M for AI-powered genomic therapies platform

New predictive biomarkers to be developed for larynx and hypopharynx carcinomas

Arpeggio Biosciences raises $17M in Series A funding to support drug pipeline

Report looks at the future of clinical trials

Finnish researchers use machine learning to unlock clinical cancer samples’ genomic code

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!